The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.

Also called NCT05095857

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05095857
  • EudraCT 2021-003716-12
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05095857. Randomized; quadruple masking; primary purpose treatment. Start 2023-09-15 (actual); primary completion 2028-09-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury
Acronym
KETA-BID
Condition
Subarachnoid Hemorrhage, Aneurysmal
Condition
Intracerebral Hemorrhage
Condition
Traumatic Brain Injury
Intervention (Drug)
S-ketamine
Intervention (Other)
Isotonic saline (placebo)
Lead sponsor
Copenhagen University Hospital, Rigshospitalet (class: other)
Collaborator
Copenhagen Trial Unit, Center for Clinical Intervention Research (class: other)

Record details

Record id
cardio:ct-nct05095857
Content hash
b75c746b027ae42126f7a2d0ee15b396db2ab753871d74b7b2c6ae311ef3bb4c